Mail-order sleep apnea diagnostic and treatment company Lofta has entered into a commercial agreement with Itamar Medical Ltd for home sleep testing devices.
Lofta will integrate Itamar’s clinically validated diagnostic tool into its process. The Itamar Medical WatchPAT is a portable sleep diagnostic device that uses peripheral arterial tonometry to enable sleep apnea diagnosis.
The Lofta Complete Path takes clients from sleep apnea diagnosis to sleep apnea treatment in as little as 5 days, all from the comfort of home.
Lofta CEO Jay Levitt, says in a release, “A desire to provide a simple, accurate, reliable solution to those struggling with sleep-disordered breathing and sleep apnea drove the decision to use Itamar’s WatchPAT technology. Lofta is committed to making the sleep apnea diagnosis process accessible and simple to everyone through advanced technology, and a user-friendly approach that has been clinically validated against polysomnography.
“Historically, the process of getting diagnosed and treated for sleep apnea has been challenging for patients who often avoid overnight sleep labs that contribute to the complexity and cost of an already difficult journey. Unfortunately, this means people who have a potentially life-threatening condition go undiagnosed, and untreated.
“Lofta clears the way to better sleep by providing access to sleep apnea screening, testing, online diagnosi, ,and comprehensive treatment support all from one place—the client’s home.”
Lofta’s director of client services Laura Avilez, adds, “Sleep apnea is a serious condition and should be treated. For this reason, the medical aspects of the Lofta Complete Path are overseen by independent board-certified sleep physicians. We aren’t your typical home sleep apnea testing company that ships out tests with little guidance or support. We stay with our clients every step of the way. We love Itamar’s WatchPAT because its advanced technology provides quick comprehensive test results. And, our clients appreciate that we can explain the results of their study in a thorough, and accessible way. When people are better informed about their condition, they are vested in their therapy outcomes.”